Pluristyx, powered by panCELLa, is a leading provider of human-derived pluripotent stem cells, offering a range of unique non-modified and genetically engineered iPSC-based technologies and services to support the development and commercialization of revolutionary therapeutics. With over 50 years of executive experience in development and manufacturing, Pluristyx simplifies the stem cell therapy development process through derivation, gene editing, product banking, and expansion services.
Through the panCELLa platform, Pluristyx provides end-to-end solutions for clients at any stage of their product development workflow, offering unparalleled functional control of commercial products through gene editing technologies. As a pioneer in the field of stem cell biology and cell therapy, Pluristyx accelerates the path to clinic and provides a seamless route to commercialization for innovative cell-based therapies.
Generated from the website